| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-623-30 | 65862-623 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20171103 | N/A | ANDA | ANDA202821 | Aurobindo Pharma Limited | FLECAINIDE ACETATE | 150 mg/1 | 30 TABLET in 1 BOTTLE (65862-623-30) |
| 65862-623-99 | 65862-623 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20171103 | N/A | ANDA | ANDA202821 | Aurobindo Pharma Limited | FLECAINIDE ACETATE | 150 mg/1 | 1000 TABLET in 1 BOTTLE (65862-623-99) |
| 50090-5306-0 | 50090-5306 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20201028 | N/A | ANDA | ANDA202821 | A-S Medication Solutions | FLECAINIDE ACETATE | 50 mg/1 | 60 TABLET in 1 BOTTLE (50090-5306-0) |
| 65862-621-30 | 65862-621 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20171103 | N/A | ANDA | ANDA202821 | Aurobindo Pharma Limited | FLECAINIDE ACETATE | 50 mg/1 | 30 TABLET in 1 BOTTLE (65862-621-30) |
| 65862-621-99 | 65862-621 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20171103 | N/A | ANDA | ANDA202821 | Aurobindo Pharma Limited | FLECAINIDE ACETATE | 50 mg/1 | 1000 TABLET in 1 BOTTLE (65862-621-99) |
| 65862-622-01 | 65862-622 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20171103 | N/A | ANDA | ANDA202821 | Aurobindo Pharma Limited | FLECAINIDE ACETATE | 100 mg/1 | 100 TABLET in 1 BOTTLE (65862-622-01) |